Skip to main content
Genesystem Co., Ltd logo

Genesystem Co., Ltd — Investor Relations & Filings

Ticker · 363250 ISIN · KR7363250002 KO Manufacturing
Open in API
Filings indexed 173 across all filing types
Latest filing 2025-02-28 Earnings Release
Country KR South Korea
Listing KO 363250

About Genesystem Co., Ltd

https://genesystem.co.kr/

Genesystem Co., Ltd. is a biotechnology engineering company specializing in the development and commercialization of molecular diagnostic solutions for point-of-care testing (POCT) applications. The company focuses on making Polymerase Chain Reaction (PCR) testing faster, simpler, and more accessible for on-site use. It develops and markets rapid PCR platforms, proprietary reagents, and biochip-based products. Key technologies include ultra-fast PCR, miniaturized heating modules, and multiplex biochip systems that enable precise and convenient analysis. Genesystem's solutions serve various markets, including human healthcare for pathogen detection and food safety for identifying foodborne pathogens and meat authentication.

Recent filings

Filing Released Lang Actions
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (GeneSystem) announcing a significant change (over 30%) in revenue or profit structure. This is a standard disclosure requirement in the Korean stock market (KRX) for listed companies to report material financial changes before the final audit report is finalized. It provides key financial highlights (revenue, operating profit, net income) and reasons for the change. Since it is an initial announcement of financial results rather than a full annual report or a report publication announcement, it falls under the 'Earnings Release' category. FY 2024
2025-02-28 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership (specifically by Korea Securities Finance Corp in Jin System Co., Ltd.) and is filed with the Financial Services Commission and the Korea Exchange. This falls under the category of Major Shareholding Notification.
2025-01-09 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a Korean company (GeneSystem) regarding a 'Single Sales/Supply Contract' amendment. It details a correction to a previously filed contract (dated 2024-03-28) due to the expiration of the contract period and updates to the final contract amount. Since this is a specific regulatory disclosure regarding a commercial contract amendment and does not fit into categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2024-12-31 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a formal regulatory disclosure regarding a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결) by the company GeneSystem. It details the contract value, counterparty, duration, and payment terms. In the context of Korean regulatory filings (DART), this is a standard material event disclosure regarding a major contract, which falls under the 'Regulatory Filings' category as it does not fit into specific categories like M&A or Share Issuance.
2024-12-31 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date for the purpose of holding an Annual General Meeting (AGM). It is a standard corporate disclosure filed with the regulatory authority to inform shareholders of the record date for voting rights. Since it is a regulatory announcement regarding a meeting procedure rather than the meeting materials themselves or a financial report, it falls under the general regulatory filing category.
2024-12-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities (Financial Supervisory Service/KRX). This is a standard regulatory filing used to disclose insider transactions, specifically the exercise of stock options by an executive (Park Young-won) of GeneSystem. In the provided classification schema, reports of personal share transactions by company directors and executives are categorized as 'Director's Dealing'.
2024-12-06 Korean

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.